Found 5 clinical trials
Cabergoline as a Preventive Treatment for Chronic Migraine
models and a study of prolactine-associated headaches have indicated that dopamine agonists such as cabergoline might be used as a treatment of migraine. The aim of this study is to test the
- 0 views
- 07 Oct, 2022
- 1 location
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
The aim of this study is to investigate whether inhibition of serum prolactin levels below normal range during cabergoline administration may reduce the recurrence rate after drug withdrawal in
- 90 views
- 27 Feb, 2022
- 1 location
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
induce tumour shrinkage. At present, cabergoline is the dopamine agonist most widely used in the treatment of pituitary adenomas secreting prolactin. Aim is to study the effect of medical
- 65 views
- 12 Sep, 2021
- 3 locations
Novel, Non-Hormonal Therapy for the Treatment of Chronic Pain Due to Endometriosis in Adolescent and Adult Women
agents inappropriate for use in reproductive-age patients. This obstacle will be overcome by performing a randomized, double blind clinical trial aimed at repurposing an existing drug, cabergoline, as a
- 18 views
- 11 Oct, 2022
- 1 location
Factors and Outcomes Associated With Postpartum Cabergoline Use
Cabergoline is frequently being requested by many postpartum women with a live newborn to suppress lactation. The aim of the study is to investigate which women desire such an intervention, and
- 30 views
- 09 Feb, 2022
- 1 location